PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0049/2023 : EMA decision of 14 July 2023 on the acceptance of a modification of an agreed paediatric investigation plan for ixekizumab (Taltz), (EMEA-001050-PIP02-18-M02)